Skip to main content

Table 2 AATK/miR-1250 methylation frequency in NHL primary samples

From: miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin’s lymphoma: novel targets with impact on ERK signaling and cell migration

Disease subtype

Sample size

Methylation (%)

B-cell NHLs

93

41 (44.09%)

 Diffuse large B-cell lymphoma (DLBCL)

56

35 (62.50%)

 Mantle cell lymphoma (MCL)

28

2 (7.14%)

 Follicular lymphoma (FL)

1

0 (0%)

 Burkitt’s lymphoma (BL)

5

4 (80.00%)

 Small lymphocytic lymphoma (SLL)

3

0 (0%)

T-cell NHLs

27

9 (33.33%)

 Peripheral T-cell lymphoma (PTCL)

20

8 (40.00%)

 Angioimmunoblastic T-cell lymphoma (AITL)

7

1 (14.29%)